Development of a pediatric differentiated thyroid carcinoma registry within the EuRRECa project: rationale and protocol

Autor: S C Clement, W E Visser, C A Lebbink, D Albano, H L Claahsen-van der Grinten, A Czarniecka, R P Dias, M P Dierselhuis, I Dzivite-Krisane, R Elisei, A Garcia-Burillo, L Izatt, C Kanaka-Gantenbein, H Krude, L Lamartina, K Lorenz, M Luster, R Navardauskaitė, M Negre Busó, K Newbold, R P Peeters, G Pellegriti, A Piccardo, A L Priego, A Redlich, L de Sanctis, M Sobrinho-Simões, A S P van Trotsenburg, F A Verburg, M Vriens, T P Links, S F Ahmed, H M van Santen

Publikováno v: Endocrine Connections, Vol 12, Iss 3, Pp 1-9 (2023)

Background: Although differentiated thyroid carcinoma (DTC) is the most freq uent endocrine pediatric cancer, it is rare in childhood and adolescence. While tumor persistence and recurrence are not uncommon, mortality remains extremely low. Compli

Externí odkaz: https://doaj.org/article/1f0e1d2e0380462fb7388c8ed45cda3b

Change of Apoptosis and Glucose Metabolism in Lung Cancer Xenografts during Cytotoxic and Anti-Angiogenic Therapy Assessed by Annexin V Based Optical Imaging and 18F-FDG-PET/CT

Autor: Dennis Doleschel, Felix M. Mottaghy, F. A. Verburg, Felix Gremse, Karin Palmowski, Anne Rix, Moritz Palmowski, Jasmin Gross, Wiltrud Lederle, Fabian Kiessling

Publikováno v: Contrast Media & Molecular Imaging, 2021:6676337. Wiley Hindawi Partnership
Contrast media & molecular imaging 2021, (2021). doi:10.1155/2021/6676337
Contrast Media & Molecular Imaging, Vol 2021 (2021)

Contrast media & molecular imaging 2021, (2021). doi:10.1155/2021/6676337
Published by Hindawi, London

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63204e56692653932b019ac70d1cf857
https://cris.maastrichtuniversity.nl/en/publications/60ef079a-5c6c-4659-be2d-ce32e6d90177

Clinical value of (6)(8)Ga-DOTATATE-PET/CT compared to stand-alone contrast enhanced CT for the detection of extra-hepatic metastases in patients with neuroendocrine tumours (NET)

Autor: Felix M. Mottaghy, O. Erdem, Florian F. Behrendt, Alexander Heinzel, F. A. Verburg, Z. Erdem, Jonas Apitzsch, D.R. Albanus

Publikováno v: European Journal of Radiology, 84(10), 1866-1872. Elsevier Ireland Ltd

Purpose To compare and outline the beneficial skills of combined 68Ga-DOTATATE positron emission tomography (PET) with concurrent contrast enhanced X-ray computed tomography (ceCT) against stand-alone ceCT in 54 patients with neuroendocrine tumours (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b128ae68db9a1738aa729d31e67e010e
https://cris.maastrichtuniversity.nl/en/publications/2583f75d-fa81-45ed-a908-1573d98e1247

Study-Parameter Impact in Quantitative 90-Yttrium PET Imaging for Radioembolization Treatment Monitoring and Dosimetry

Autor: Felix M. Mottaghy, Florian F. Behrendt, A. Goedicke, F. A. Verburg, Oliver Winz, Yannick Berker

Publikováno v: Ieee Transactions on Medical Imaging, 32(3), 485-492. IEEE

A small positron-generating branch in 90-Yttrium ((90)Y) decay enables post-therapy dose assessment in liver cancer radioembolization treatment. The aim of this study was to validate clinical (90)Y positron emission tomography (PET) quantification, f

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba1bc1cf16e9a2eb74d62563440b4d3
https://doi.org/10.1109/tmi.2012.2221135

131I therapy in patients with benign thyroid disease does not conclusively lead to a higher risk of subsequent malignancies

Autor: F. A. Verburg, C. Reiners, Michael Lassmann, Markus Luster

Publikováno v: Nuklearmedizin. 50:93-99

SummaryDue to its excellent tolerability and low incidence of side effects, 131I therapy has been the treatment of choice for benign thyroid diseases for over 60 years. A potentially increased risk of malignancies due to this therapy is however still

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9db6cc60e3c277f837f45a813299b240
https://doi.org/10.3413/nukmed-0341-10-08